For
the quarter ending Dec 2022, consolidated Net sales (including other operating income) of Max Healthcare Institute has increased 16.97% to Rs 1141.24 crore compared to quarter ended Dec 2021. Operating profit margin has jumped from 25.35% to 27.47%, leading to 26.72% rise in operating profit to Rs 313.45 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 21.20% to 20.60%. Employee cost decreased from 19.23% to 17.83%. Other expenses rose from 34.13% to 34.27%. Consultancy Management service cost fell from 21.72% to 21.13%. Other income fell 4.10% to Rs 45.15 crore. PBIDT rose 21.79% to Rs 358.6 crore. Provision for interest fell 19.67% to Rs 20.13 crore.
PBDT rose 25.65% to Rs 338.47 crore. Provision for depreciation rose 3.24% to Rs 57.03 crore.
Profit before tax grew 31.43% to Rs 281.44 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 59.03 crore, compared to Rs 23.29 crore. Effective tax rate was 20.97% compared to 10.93%.
Minority interest was nil in both the periods. Net profit attributable to owners of the company increased 17.21% to Rs 222.41 crore. Promoters’ stake was 23.78% as of 31 December 2022 ,compared to 60.68% as of 31 December 2021 .
For year-to-date (YTD) results analysis.
Net sales (including other operating income) of Max Healthcare Institute has increased 11.63% to Rs 3344.63 crore.
Operating profit margin has jumped from 24.56% to 26.81%, leading to 21.87% rise in operating profit to Rs 896.73 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 24.44% to 26.36%. Employee cost decreased from 19.63% to 17.88%. Other expenses fell from 31.47% to 29.01%. Consultancy Management service cost rose from 19.63% to 21.61%. Other income rose 3.39% to Rs 102.48 crore. PBIDT rose 19.67% to Rs 999.21 crore. Provision for interest fell 18.28% to Rs 64.33 crore.
PBDT rose 23.62% to Rs 934.88 crore. Provision for depreciation rose 5.62% to Rs 171.84 crore.
Profit before tax grew 28.56% to Rs 763.04 crore. Share of profit/loss were nil in both the periods. Provision for tax was credit of Rs 89.55 crore, compared to debit of Rs 103.19 crore. Effective tax rate was negative 11.74% compared to 17.65%.Minority interest was nil in both the periods. Net profit attributable to owners of the company increased 77.14% to Rs 852.59 crore.
Promoters’ stake was 23.78% as of 31 December 2022 ,compared to 60.68% as of 31 December 2021 .
Full year results analysis.
Net sales (including other operating income) of Max Healthcare Institute has increased 56.97% to Rs 3931.46 crore. Operating profit margin has jumped from 16.12% to 23.97%, leading to 133.39% rise in operating profit to Rs 942.56 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 23.31% to 23.62%. Employee cost decreased from 23.64% to 19.29%. Other expenses fell from 36.84% to 33.16%. Consultancy Management service cost fell from 21.40% to 20.55%. Other income rose 11% to Rs 127.36 crore. PBIDT rose 106.31% to Rs 1069.92 crore. Provision for interest fell 43.79% to Rs 100.87 crore. Loan funds declined from Rs 1,101.41 crore as of 31 March 2021 to Rs 913.38 crore as of 31 March 2022. Inventories rose to Rs 61.36 crore as of 31 March 2022 from Rs 53.80 crore as of 31 March 2021. Sundry debtors were higher at Rs 385.36 crore as of 31 March 2022 compared to Rs 365.89 crore as of 31 March 2021. Cash and bank balance declined from Rs 652.92 crore as of 31 March 2021 to Rs 499.31 crore as of 31 March 2022. Investments stood at Rs 0.51 crore as of 31 March 2022 to Rs 0.51 crore as of 31 March 2021.
PBDT rose 185.74% to Rs 969.05 crore. Provision for depreciation rose 27.01% to Rs 221.12 crore. Fixed assets increased to Rs 4,714.04 crore as of 31 March 2022 from Rs 4,108.65 crore as of 31 March 2021. Intangible assets stood at Rs 2,454.66 crore.
Profit before tax grew 353.15% to Rs 747.93 crore. Share of profit/loss were nil in both the periods. Extraordinary items were increased to Rs -9.03 crore. Provision for tax was expense of Rs 133.85 crore, compared to Rs 45.85 crore. Effective tax rate was 18.11% compared to negative 50.00%.
Minority interest was nil in both the periods.
Equity capital increased from Rs 965.95 crore as of 31 March 2021 to Rs 969.61 crore as of 31 March 2022. Per share face Value remained same at Rs 10.00.
Promoters’ stake was 50.64% as of 31 March 2022 ,compared to 70.46% as of 31 March 2021 . Promoters pledged stake was 51.15% as of 31 March 2022
Cash flow from operating activities increased to Rs 748.49 crore for year ended March 2022 from Rs 117.86 crore for year ended March 2021. Cash flow used in acquiring fixed assets during the year ended March 2022 stood at Rs 561.31 crore, compared to Rs 118.42 crore during the year ended March 2021.
Other Highlights
In
Q3 FY23, Network gross revenue grew 13%, on YoY basis.
Bed
occupancy in Q3 FY23 stood at 77%. During the quarter